Biotechnology News

December 18, 2012

NEW YORK--(BUSINESS WIRE)--Retrophin completes reverse merger with Desert Gateway

December 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the United States, 30 to 40 percent of relapsing and progressive multiple...

December 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, from 2011 to 2021, the launch of five targeted biologic therapies for gastric...

December 18, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems has been issued a patent, covering the T2MR platform, which is used in T2 Bio’s T2Dx device for direct detection of analytes, including T2Candida, the lead product in T2 Bio’s pipeline.

December 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metabolix announced that I6001, a biobased polymeric modifier for PVC formulations based on Metabolix PHA resin, is now available for shipment to customers.

December 18, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles' ClinicalResearch.com website has received its third Web Health Award in as many years, this year for a Cancer Microsite.

December 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Endeavor Power Corporation (“Endeavor Power” or the “Company”) (OTCQB: EDVP) would like to bring its shareholders up to date on the Company’s completion of the merger between its wholly owned subsidiary,...

December 18, 2012

MIAMI--(BUSINESS WIRE)--OPKO completes acquisition of CLIA Laboratory

December 18, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenASIs Version 7.2 introduces major enhancements to ASI’s offering of existing imaging applications and positions ASI as a leader in both cytogenetic and pathology imaging and analysis.

December 18, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals today announced the appointment of industry veteran Fred M. Powell, CPA, as chief financial officer.

December 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the benign prostatic hyperplasia/male lower urinary tract symptoms (BPH/LUTS)...

December 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of hepatitis C virus (HCV), the elimination of interferons (...

December 18, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announces first enrollment in the ILUMIEN I study aimed at improving clinical outcomes for physicians by offering stent guidance parameters.

December 18, 2012

PITTSBURGH--(BUSINESS WIRE)--CardiacAssist receives FDA approval for use of the TandemHeart System in pivotal clinical trial to determine effect of ventricular unloading on myocardial salvage after acute myocardial infarction.

December 18, 2012

WASHINGTON & SARATOGA, Calif.--(BUSINESS WIRE)--The Ballenger Trust supports the Myelin Repair Foundation to advance myelin repair therapeutics for Multiple Sclerosis

December 18, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Avaxia raised $6.4 million in a Series B financing from angel investors. Proceeds will be used to conduct a clinical trial of AVX-470, a gut-targeted therapeutic for inflammatory bowel disease.

December 18, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Fingerprint Cards (FPC)(STO:FINGB) has received its third Design Win (DW) for its swipe sensor technology from one of Japan’s leading and most innovative mobile phone manufacturers. The first model...

December 18, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Blend Therapeutics, a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases, announced today the appointment of Mark Iwicki as the company’s President and CEO.

December 18, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases, announced today that it has secured a $16 million Series B financing.

December 18, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead and Shire Enter into Collaboration and License Agreement to Develop Peptide-Targeted Therapeutics

December 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that Kenneth DiPietro,...

December 18, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics closed a $3M round of private equity financing to support a Phase 1b clinical trial of T-type calcium channel inhibitors in brain cancer as well as other new therapies and diagnostics

December 18, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Ortho Kinematics‚ Inc. (OKI), a privately held healthcare diagnostics company focused on spine imaging informatics, announced today the close of more than $2 million in its Series B financing. These new funds will...

December 18, 2012

ZURICH & DUESSELDORF, Germany--(BUSINESS WIRE)--Leaders from the international medical technology industry will gather May 7–8 in Duesseldorf, Germany, for the fifth annual EuroMedtech™ partnering conference. In 2012, the conference hosted...

December 18, 2012

OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--e-Therapeutics provides an update on the clinical trials of its cancer drug ETS2101. Two phase I studies remain on track to report final data in Q4 2013 and Q1 2014, respectively.

December 18, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies, (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, announced today its financial calendar for 2013*. Financial publications...

December 18, 2012

TAINAN, Taiwan--(BUSINESS WIRE)--A wireless physiological monitoring system designed by the Department of Biomedical Engineering (BME) of National Cheng Kung University (NCKU), southern Taiwan, has proved to increase medical efficiency and safety...

December 18, 2012

PASADENA, Calif.--(BUSINESS WIRE)--The EPO notified Genervon of its intention to grant a patent on Methods of Treating Neuronal Disorders using MNTF peptides for stroke, SCI, HD, PD, MS, ALS, and AD. Brings patent portfolio to 46.

December 17, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) announced today that a combined panel of experts from the American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) have updated their guidelines to include a...

December 17, 2012

SEATTLE--(BUSINESS WIRE)--Adrian Cheng, a scientist at the Allen Institute for Brain Science, was named today in Forbes’ second annual “30 Under 30” list of tomorrow’s brightest stars. Cheng invented a powerful microscope technology that can...

December 17, 2012

WASHINGTON--(BUSINESS WIRE)--Today the Biotechnology Industry Organization (BIO) announced registration and housing are now open for the 2013 World Congress on Industrial Biotechnology and Bioprocessing. This unique conference will be held June...

December 17, 2012

WASHINGTON--(BUSINESS WIRE)--Premier letter to FDA supports generic drug industry’s Accelerated Recovery Initiative

December 17, 2012

NEW YORK--(BUSINESS WIRE)--The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 24-cent first-quarter 2013 dividend on the company’s common stock, payable March 5, 2013, to shareholders of record at the close of business on February...

December 17, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation is pleased to announce that The Scientist has named NanoLuc™ Luciferase Technology to its 2012 Top 10 Innovations.

December 17, 2012

LAUSANNE, Switzerland--(BUSINESS WIRE)--A study by Pantaleo and Perreau published online in The Journal of Experimental Medicine identified the population of CD4 T cells serving as major reservoir for HIV infected cells.

December 17, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac Discovery is pleased to announce the selection of a preclinical development candidate from its allosteric Akt inhibitor programme. Akt is a key component of the PI3K pathway, one of the major...

December 17, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has signed an agreement with Octane...

December 17, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for OTREXUP™, a combination product for the delivery of methotrexate (...

December 17, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that the Brazilian market for atrial fibrillation will increase at a rate of 31...

December 17, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the United States, approximately 80 percent of current prescribers of Janssen...

December 17, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that after one full year on the market, over 75 percent of surveyed rheumatologists have...

December 17, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group and AMR in their TreatmentTrends®: Clostridium difficile Infections (U.S.) report find that metronidazole and oral vancomycin continue to be the workhorse drugs for the treatment of...

December 17, 2012

TOKYO--(BUSINESS WIRE)--Bridge Report on R-Tech Ueno Issued: Mixed First Half Earnings, Long Term Earnings Potential Remains Strong

December 17, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC or the “Company”), a leader in the field of regenerative medicine, today announced treatment of the fifth and sixth patients in the company’s European...

December 17, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Promedior announced the opening its new office and laboratory space at 101 Hartwell Avenue, Lexington, Massachusetts.

December 17, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. today announced the appointment of Joel Schaedler as vice president of market access and Daniel Martin as vice president of marketing.

December 17, 2012

CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) announced today that LINZESS™ (linaclotide) is now available in pharmacies throughout the United States. The...

December 17, 2012

WOBURN, Mass.--(BUSINESS WIRE)--Aphios was granted a patent for oral delivery of insulin encapsulated in biodegradable polymer nanospheres using the Company’s proprietary PNS technology platform.